Biogen | Capitalisation Boursière

Market Capitalization Changement Date
AbbVie USD 273.6B 10.51B 2023-12
Acadia Pharmaceuticals USD 5.14B 1.73B 2023-12
Acorda Therapeutics USD 16M 2M 2023-06
ALKERMES USD 4.63B 36M 2023-12
Amgen USD 154.14B 10.38B 2023-12
Bayer EUR 33.04B 11.61B 2023-12
Biogen USD 37.5B 274M 2023-12
BioMarin Pharmaceutical USD 18.16B 1.51B 2023-12
Bluebird Bio USD 325M 25M 2023-09
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Esperion Therapeutics USD 340M 235M 2023-12
Gilead Sciences USD 100.94B 7.57B 2023-12
Incyte USD 12.89B 1.18B 2024-03
Intra Cellular Therapies USD 6.67B 227M 2024-03
Marinus Pharmaceuticals USD 407M 142M 2023-09
Merck USD 314.33B 38.07B 2024-03
Moderna USD 40.08B 2.16B 2024-03
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Pfizer USD 155.51B 7.05B 2024-03
PTC Therapeutics USD 2.22B 145M 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Sanofi EUR 113.53B 14.8B 2023-12
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Teva Pharmaceutical Industries ILS 42.76B 315.46M 2023-12
Ultragenyx Pharmaceutical USD 3.77B 153M 2024-03
United Therapeutics USD 11.05B 721M 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03



Biogen Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.